Stocks
Health Care
srpt
Sarepta Therapeutics
NASDAQ: SRPT
+0.27 (+1.46%)
18.425
USD
At close at Sep 03, 15:38 UTC
Income Statement
Revenue
1.90B
Gross Profit
1.58B
Operating Income
218.08M
Pretax Income
-164.19M
Net Income
235.24M
EBITDA
314.67M
EBIT
260.77M
Earnings Per Share
2.4699999999999998
Balance Sheet
Cash & Cash Equivalents
527.94M
Total Debt
1.37B
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
1.20B
Book Value Per Share
12.62
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.